Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Role of the Immunogenic and Tolerogenic Subsets of Dendritic Cells in Multiple Sclerosis.
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis.
In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects.
Phospholipase D1 mediates lymphocyte adhesion and migration in experimental autoimmune encephalomyelitis.
Does Lipoic Acid Consumption Affect the Cytokine Profile in Multiple Sclerosis Patients: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Transcriptional de-repression of ERVWE1 following influenza A virus infection.
A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci.
Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data.
Vital role of specialist MS nurses recognised in proposed guideline.
The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?
Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status.
Association of methylenetetrahydrofolate reductase A1298C polymorphism but not of C677T with multiple sclerosis in Tunisian patients.
Anti-interleukin-2 receptor alpha for multiple sclerosis?
Autoantibody profiling in multiple sclerosis using arrays of human protein fragments.
Acute Disseminated Encephalomyelitis (ADEM)-A Rare Complication of Falciparum Malaria.
A Sphingosine-1-Phosphate Receptor 1-Directed Agonist Reduces Central Nervous System Inflammation in a Plasmacytoid Dendritic Cell-Dependent Manner.
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis.
Remission of Severe Myasthenia Gravis After Massive-Dose Vitamin D Treatment.
Acute retinal necrosis in multiple sclerosis: A neuroimmunologic challenge!
Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis optica.
Benefits, safety, and prescription of exercise in persons with multiple sclerosis.
Tysabri Review Launched in Europe
Metabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control study.
Scutellarin Alleviates Behavioral Deficits in a Mouse Model of Multiple Sclerosis, Possibly Through Protecting Neural Stem Cells.
The effect of group psycho-education program on the burden of family caregivers with multiple sclerosis patients in Isfahan in 2013-2014.
Pages
« first
‹ previous
…
381
382
383
384
385
386
387
388
389
…
next ›
last »